Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer.
Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S, Kohagura K, Matsubara Y, Sugawara Y, Yamanaka T, Yamashita T, Shimizu S, Narimatsu H.
Haneda E, et al.
Int J Environ Res Public Health. 2022 May 19;19(10):6182. doi: 10.3390/ijerph19106182.
Int J Environ Res Public Health. 2022.
PMID: 35627717
Free PMC article.
Review.